img

Global Bulk Drug Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global Bulk Drug Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Bulk Drug Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Bulk Drug industry at home and abroad, estimate the overall market scale of the Bulk Drug industry and the market share of major countries, Bulk Drug industry, and study and judge the downstream market demand of Bulk Drug through systematic research, Analyze the competition pattern of Bulk Drug, so as to help solve the pain points of various stakeholders in Bulk Drug industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Bulk Drug Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Bulk Drug Market?
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Major Type of Bulk Drug Covered in XYZResearch report
Vitamin
Antibiotic
Iohexol
Hormone
Amino Acid
Application Segments Covered in XYZResearch Market
Orthopedics Disease
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Bulk Drug Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Bulk Drug Market by Value
2.2.1 Global Bulk Drug Revenue by Type
2.2.2 Global Bulk Drug Market by Value (%)
2.3 Global Bulk Drug Market by Production
2.3.1 Global Bulk Drug Production by Type
2.3.2 Global Bulk Drug Market by Production (%)

3. The Major Driver of Bulk Drug Industry
3.1 Historical & Forecast Global Bulk Drug Demand
3.2 Largest Application for Bulk Drug (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Bulk Drug Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Bulk Drug Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Bulk Drug Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Bulk Drug Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Bulk Drug Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Bulk Drug Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Bulk Drug Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Bulk Drug Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Bulk Drug Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Bulk Drug Average Price Trend
12.1 Market Price for Each Type of Bulk Drug in US (2018-2022)
12.2 Market Price for Each Type of Bulk Drug in Europe (2018-2022)
12.3 Market Price for Each Type of Bulk Drug in China (2018-2022)
12.4 Market Price for Each Type of Bulk Drug in Japan (2018-2022)
12.5 Market Price for Each Type of Bulk Drug in India (2018-2022)
12.6 Market Price for Each Type of Bulk Drug in Korea (2018-2022)
12.7 Market Price for Each Type of Bulk Drug in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Bulk Drug Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Bulk Drug

14. Bulk Drug Competitive Landscape
14.1 Teva
14.1.1 Teva Company Profiles
14.1.2 Teva Product Introduction
14.1.3 Teva Bulk Drug Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Novartis
14.2.1 Novartis Company Profiles
14.2.2 Novartis Product Introduction
14.2.3 Novartis Bulk Drug Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Pfizer
14.3.1 Pfizer Company Profiles
14.3.2 Pfizer Product Introduction
14.3.3 Pfizer Bulk Drug Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Johnson & Johnson
14.4.1 Johnson & Johnson Company Profiles
14.4.2 Johnson & Johnson Product Introduction
14.4.3 Johnson & Johnson Bulk Drug Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Mylan
14.5.1 Mylan Company Profiles
14.5.2 Mylan Product Introduction
14.5.3 Mylan Bulk Drug Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 North China Pharmaceutical Group
14.6.1 North China Pharmaceutical Group Company Profiles
14.6.2 North China Pharmaceutical Group Product Introduction
14.6.3 North China Pharmaceutical Group Bulk Drug Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Dr. Reddy’s Laboratories
14.7.1 Dr. Reddy’s Laboratories Company Profiles
14.7.2 Dr. Reddy’s Laboratories Product Introduction
14.7.3 Dr. Reddy’s Laboratories Bulk Drug Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Roche
14.8.1 Roche Company Profiles
14.8.2 Roche Product Introduction
14.8.3 Roche Bulk Drug Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Aurobindo pharma
14.9.1 Aurobindo pharma Company Profiles
14.9.2 Aurobindo pharma Product Introduction
14.9.3 Aurobindo pharma Bulk Drug Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Sun Pharmaceutical Industries
14.10.1 Sun Pharmaceutical Industries Company Profiles
14.10.2 Sun Pharmaceutical Industries Product Introduction
14.10.3 Sun Pharmaceutical Industries Bulk Drug Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Boehringer Ingelheim GmbH
14.12 Bayer
14.13 BASF
14.14 DSM
14.15 Zhejiang Medicine
14.16 Biocon
14.17 Johnson Matthey
14.18 Hisun Pharmacy
14.19 Cambrex
14.20 Shandong Xinhua Pharmaceutical
14.21 Lonza group
14.22 Huahai Pharmaceutical
14.23 Haerbin Pharmaceutical Group
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Bulk Drug Industry (Volume)
Figure 2. Bulk Drug Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Bulk Drug Revenue in 2022
Figure 5. US Bulk Drug Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Bulk Drug Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Bulk Drug Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Bulk Drug Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Bulk Drug Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Bulk Drug Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Bulk Drug Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Bulk Drug Revenue, by Type (Million USD) (2018-2028)
Table 4. Bulk Drug Production, by Type (K Unit) (2018-2028)
Table 5. Bulk Drug Demand (K Unit) by Application (2018-2028)
Table 6. Bulk Drug Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Bulk Drug Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Bulk Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Bulk Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Bulk Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Bulk Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Bulk Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Bulk Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Bulk Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Bulk Drug in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Bulk Drug in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Bulk Drug in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Bulk Drug in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Bulk Drug in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Bulk Drug in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Bulk Drug in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Teva Profiles
Table 61. Teva Bulk Drug Product Introduction
Table 62. Teva Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Teva Strategic initiatives
Table 64. Novartis Profiles
Table 65. Novartis Bulk Drug Product Introduction
Table 66. Novartis Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Novartis Strategic initiatives
Table 68. Pfizer Profiles
Table 69. Pfizer Bulk Drug Product Introduction
Table 70. Pfizer Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Pfizer Strategic initiatives
Table 72. Johnson & Johnson Profiles
Table 73. Johnson & Johnson Bulk Drug Product Introduction
Table 74. Johnson & Johnson Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Johnson & Johnson Strategic initiatives
Table 76. Mylan Profiles
Table 77. Mylan Bulk Drug Product Introduction
Table 78. Mylan Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Mylan Strategic initiatives
Table 80. North China Pharmaceutical Group Profiles
Table 81. North China Pharmaceutical Group Bulk Drug Product Introduction
Table 82. North China Pharmaceutical Group Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. North China Pharmaceutical Group Strategic initiatives
Table 84. Dr. Reddy’s Laboratories Profiles
Table 85. Dr. Reddy’s Laboratories Bulk Drug Product Introduction
Table 86. Dr. Reddy’s Laboratories Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Dr. Reddy’s Laboratories Strategic initiatives
Table 88. Roche Profiles
Table 89. Roche Bulk Drug Product Introduction
Table 90. Roche Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Roche Strategic initiatives
Table 92. Aurobindo pharma Profiles
Table 93. Aurobindo pharma Bulk Drug Product Introduction
Table 94. Aurobindo pharma Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Aurobindo pharma Strategic initiatives
Table 97. Sun Pharmaceutical Industries Profiles
Table 98. Sun Pharmaceutical Industries Bulk Drug Product Introduction
Table 99. Sun Pharmaceutical Industries Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Sun Pharmaceutical Industries Strategic initiatives
Table 101. Boehringer Ingelheim GmbH Profiles
Table 102. Boehringer Ingelheim GmbH Bulk Drug Product Introduction
Table 103. Boehringer Ingelheim GmbH Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Boehringer Ingelheim GmbH Strategic initiatives
Table 105. Bayer Profiles
Table 106. Bayer Bulk Drug Product Introduction
Table 107. Bayer Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Bayer Strategic initiatives
Table 109. BASF Profiles
Table 110. BASF Bulk Drug Product Introduction
Table 111. BASF Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. BASF Strategic initiatives
Table 113. DSM Profiles
Table 114. DSM Bulk Drug Product Introduction
Table 115. DSM Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 116. DSM Strategic initiatives
Table 117. Zhejiang Medicine Profiles
Table 118. Zhejiang Medicine Bulk Drug Product Introduction
Table 119. Zhejiang Medicine Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 120. Zhejiang Medicine Strategic initiatives
Table 121. Biocon Profiles
Table 122. Biocon Bulk Drug Product Introduction
Table 123. Biocon Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 124. Biocon Strategic initiatives
Table 125. Johnson Matthey Profiles
Table 126. Johnson Matthey Bulk Drug Product Introduction
Table 127. Johnson Matthey Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 128. Johnson Matthey Strategic initiatives
Table 129. Hisun Pharmacy Profiles
Table 130. Hisun Pharmacy Bulk Drug Product Introduction
Table 131. Hisun Pharmacy Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 132. Hisun Pharmacy Strategic initiatives
Table 133. Cambrex Profiles
Table 134. Cambrex Bulk Drug Product Introduction
Table 135. Cambrex Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 136. Cambrex Strategic initiatives
Table 137. Shandong Xinhua Pharmaceutical Profiles
Table 138. Shandong Xinhua Pharmaceutical Bulk Drug Product Introduction
Table 139. Shandong Xinhua Pharmaceutical Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 140. Shandong Xinhua Pharmaceutical Strategic initiatives
Table 141. Lonza group Profiles
Table 142. Lonza group Bulk Drug Product Introduction
Table 143. Lonza group Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 144. Lonza group Strategic initiatives
Table 145. Huahai Pharmaceutical Profiles
Table 146. Huahai Pharmaceutical Bulk Drug Product Introduction
Table 147. Huahai Pharmaceutical Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 148. Huahai Pharmaceutical Strategic initiatives
Table 149. Haerbin Pharmaceutical Group Profiles
Table 150. Haerbin Pharmaceutical Group Bulk Drug Product Introduction
Table 151. Haerbin Pharmaceutical Group Bulk Drug Production (Unit), Revenue (Million USD) (2018-2022)
Table 152. Haerbin Pharmaceutical Group Strategic initiatives